Annual Report 2018

OPERATING PROGRAMME

Grants
 
  Astra Zeneca € 30,000
  Boehringer Ingelheim € 30,000
  Chiesi € 30,000
  GSK € 30,000
  Novartis € 30,000
  Pfizer € 30,000
  Regeneron € 30,000
  Sanofi Genzyme* -
  SigAirHandling € 30,000
  Stallergenes € 30,000
Membership fees
€ 14,500

EFA PROJECT PROGRAMME

Severly, ASTHMA!
 
  Chiesi € 10,000
  GSK € 10,000
  Novartis € 10,000
  Regeneron € 12,000
  Sanofi Genzyme € 12,000
 Capacity Building**
 
  Boehringer ingelheim € 30,000
  Novartis € 30,500
European Parliament Interest Group on Allergy and Asthma 
  Novartis € 11,667
  Stallergenes € 11,667
European Atopic Eczema Awareness Day
 
  Regeneron € 65,000
  Sanofi Genzyme € 65,000
Active Patients Access Care survey***
 
  Chiesi € 38,878
  GSK € 37,878
  AstraZeneca € 77,956

*Sanofi Genzyme partnership ended November 2018 and is been renewed

**4,500 EUR from Capacity Building (Novartis) moved to 2019 to cover Meet&Greet expenses

***88,488 EUR from Access Survey moved to 2019 to cover project activities